Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s): CRDL

Healthcare

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.

TSX:CRDL - Post by User

Cardiol Therapeutics Inc > AGM June 29th @ 4:30 EST

<< Previous

Bullboard Posts

Next >>

Comment by Youhillmanon Jun 28, 2021 10:12am

220 Views

Post# 33459268

RE:AGM June 29th @ 4:30 EST

AGM is tomorrow, looking forward to a better AGM than the one last year where they couldn't comment on anything because of the bought deal they did around the AGM. I thought it was a joke of an AGM and a waste of everyone's time, no excuse this time!

Looking forward to hearing more about:

1) NASDAQ listing
2) COVID Trials
3) Phase 2 AM
4) Sales at Shoppers

Link to the AGM is below.

Youhillman wrote: Looking forward to the AGM next month.

Here are the details...

Next SP catalyst is the NASDAQ listing, anticipating that to occur in June or July at the latest.

I'm long on CRDL!

2021 Annual General Meeting

When: Tuesday, June 29, 2021 4:30pm (Eastern Time)

Where: Virtually online at web.lumiagm.com/448532842

• 2021 Notice of Annual General Meeting of Shareholders: Download PDF
• 2021 Management Information Circular: Download PDF
• 2021 Form of Proxy: Download PDF
• Virtual AGM User Guide: Download PDF